High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival and strong anti-tumor immunity

by Andreou, A., Gloor, B., Karamitopoulou, E., Perren, A., Wenning, A.S
Published 2022

Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment

by Balachandran, V.P, Buisman, F.E, Cercek, A., D'Angelica, M.I, Drebin, J.A, Galjart, B., Giardiello, D., Gönen, M., Grünhagen, D.J, Höppener, D.J, Jarnagin, W.R, Kemeny, N.E, Kingham, T.P, Koerkamp, B.G, Nierop, P.M.H, Steyerberg, E.W, Verhoef, C., Vermeulen, P.B, Wei, A.C
Published 2022

Cancer mortality predictions for 2021 in Latin America

by Bertuccio, P., Boffetta, P., Carioli, G., La Vecchia, C., Levi, F., Malvezzi, M., Negri, E.
Published 2022

Increased survival in non-endometrioid endometrial cancer after introducing lymphadenectomy and tailoring radiotherapy – A population-based cohort study

by Adok, C., Åkesson, Å, Dahm-Kähler, P.
Published 2022

Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study

by Aerts, J.G, Bezemer, K., de Koning, W., de Miranda, N.F.C.C, Doukas, M., Dumas, J., Klaase, L., Lau, S.P, Luider, T.M, Mustafa, D.A.M, Nunes, J.B, Stadhouders, R., Stingl, C., Stubbs, A.P, van der Breggen, R., van der Burg, S.H, van Eijck, C.H.J, van Krimpen, A., Vink, M., Vroman, H., Wismans, L.V
Published 2022

Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort

by Harano, K., Kobayashi, K., Kogawa, T., Masuda, N., Mizutani, M., Mukohara, T., Nagai, R., Okumura, S., Ono, M., Ren, M., Semba, T., Shimoi, T., Suzuki, T., Takahashi, S., Takase, T., Tanioka, M., Yasojima, H., Yonemori, K., Zhao, Z.-M
Published 2022

Updated evidence-based recommendations for cervical cancer screening in France

by Arbyn, M., Hamers, F.F, Poullié, A.-I
Published 2022

Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma

by Bechmann, N., Berends, A.M.A, Beuschlein, F., Constantinescu, G., Eisenhofer, G., Januszewicz, A., Kerstens, M.N, Lenders, J.W.M, Meuter, L., Pacak, K., Pamporaki, C., Prodanov, T., Remde, H., Robledo, M., Taïeb, D., Timmers, H.J.L.M
Published 2022

Risk factors of cervical cancer among ethnic minorities in Yunnan Province, China: a case-control study

by Chen, B., Chen, H.-F, Ding, S.-R, Gao, C.-X, Gu, R.-Y, Jia, Y., Luo, L., Xu, X.-B, Zhao, M.
Published 2022

Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in th...

by Alba, E., Alonso-Romero, J.L, Antón, A., Bermejo, B., Calvo, L., Carrasco, E., Casas, M.I, Ciruelos, E.M, Corsaro, M., Csöszi, T., de la Haba-Rodríguez, J., Gil-Gil, M., Huang, X., Kahan, Z., Margelí, M., Martín, M., Morales, S., Muñoz, M., Murillo, L., Ramos, M., Ruiz-Borrego, M., Sánchez-Rovira, P., Santaballa, A., Thallinger, C., Turner, N., Zielinski, C.
Published 2022

Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors

by Drobni, Z.D, Gilman, H.K, Jain, R.K, Merkely, B., Michielin, O., Muller, V., Neilan, T.G, Pittet, M.J, Quinaglia, T., Reynolds, K.L, Sullivan, R.J, Supraja, S., Zlotoff, D.A, Zubiri, L.
Published 2022